Actively Recruiting
Tackling Disruptions to Frailty Interventions: Developing Personalized Interventions Targeted for Older Persons With Cardiac Frailty
Led by National Heart Centre Singapore · Updated on 2025-06-05
500
Participants Needed
6
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Muscle mass loss and metabolic dysfunction, exacerbated by inactivity and nutritional inadequacies, underpin both cardiovascular disease and frailty in ageing. The investigators' proposal seeks to develop interventions in exercise and diet that are targeted for older adults with cardiac frailty. Methods: The investigators' proposal is a five-year study comprising of first phase (first 2-2.5 years) and second phase (next 2-2.5 years). In the first phase cardiac frail participants (up to N=500) from each healthcare transition (inpatient hospital, step-down community hospital, outpatient clinic/community) will be randomized to receive Intervention Sets or usual care. The second phase will scale up these programs. Three Intervention Sets A, B, and C will be implemented in the outpatient, step-down community hospital, and acute hospital settings. Diet intervention comprises meal sets prepared with nutrients involved in energy metabolism. Exercise training is facilitated by hospital gyms and hospital physiotherapists. Diet and exercise behavior will be monitored using questionnaires, video conferencing and meal photos. Significance: Clinical studies are urgently needed using consistent frailty tools to evaluate the efficacy and promise of frailty interventions, targeted to achieve reversal/retardation of frailty. When scaled up, these approaches will provide high-quality science needed to manage cardiac frailty towards healthier population ageing.
CONDITIONS
Official Title
Tackling Disruptions to Frailty Interventions: Developing Personalized Interventions Targeted for Older Persons With Cardiac Frailty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 21 years or older
- Able to walk outdoors
You will not qualify if you...
- Bed-bound status
- Dementia stage 6 or higher
- Living in sheltered or nursing homes
- Having cancer
- Participating in ongoing clinical trials involving drugs or devices
- Uncontrolled hypertension (systolic 4160 mmHg or diastolic 490 mmHg) despite treatment
- Low blood pressure (systolic <90 mmHg or diastolic <40 mmHg)
- Uncontrolled atrial fibrillation (controlled allowed)
- Ventricular arrhythmias such as ventricular tachycardia
- Renal failure requiring dialysis
- Chronic kidney disease stage 4 or above
- Nephrotic syndrome
- Liver cirrhosis Child's B or higher
- Inflammatory bowel disease
- Severe uncontrolled gout
- Poorly controlled diabetes with Hba1c 49%
- Taking warfarin
- Having food allergies such as shellfish or prawn
- Life expectancy less than one year as assessed by investigator
- Receiving nasogastric or parenteral nutrition
- Hypertrophic cardiomyopathy
- Cardiac amyloidosis
- Cardiac sarcoidosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Alexandra Hospital
Singapore, Singapore, 159964
Actively Recruiting
2
National Heart Centre Singapore
Singapore, Singapore, 169609
Actively Recruiting
3
Changi General Hospital
Singapore, Singapore, 529889
Actively Recruiting
4
Sengkang General Hospital
Singapore, Singapore, 544886
Actively Recruiting
5
Jurong Community Hospital
Singapore, Singapore, 609606
Actively Recruiting
6
NHG Polyclinics
Singapore, Singapore
Actively Recruiting
Research Team
A
Angela Su-Mei Koh
CONTACT
G
Gina Sihui Lee
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here